HIVE Digital Technologies (HIVE) Stock: -28.6% Pullback After Major AI Contract and Convertible Notes
Key Takeaways
- HIVE shares declined approximately 28.6% over the past 30 days, retreating from a year-to-date high of $5.34 reached on June 22 to around $3.24 as of early July.
- The pullback followed a massive rally driven by a landmark $220 million sovereign AI GPU cloud contract with Bell Canada and Cohere, announced on June 18.
- An upsized $115 million convertible note offering priced on June 25 triggered dilution concerns and accelerated profit-taking among short-term traders.
- Despite the 30-day decline, HIVE remains up roughly 69% over the full quarter, reflecting a broader transformation from a pure-play Bitcoin miner into an AI and high-performance computing infrastructure company.
- Analyst sentiment remains broadly positive, with Cantor Fitzgerald, B. Riley, and Rosenblatt all raising price targets following the AI contract announcement.
HIVE Digital Technologies' Evolution Into AI Infrastructure
HIVE Digital Technologies Ltd. operates data centers across Canada, Sweden, and Paraguay. Founded in 2017 as one of the first publicly listed cryptocurrency miners powered by green energy, the company has developed a dual business model. It continues to run a meaningful Bitcoin mining operation while expanding aggressively into high-performance computing and AI cloud services through its subsidiary BUZZ High Performance Computing Inc. The focus on NVIDIA GPU clusters for enterprise AI workloads and sovereign cloud infrastructure has helped reposition HIVE from a crypto-focused name to an emerging player in AI infrastructure, drawing interest from investors tracking compute capacity.
Recent Stock Performance: 30-Day Decline Versus Quarterly Gains
Over the last 30 days, HIVE shares reversed sharply. The stock closed at $4.54 on June 2 and reached a year-to-date peak of $5.34 on June 22 on the back of the large AI infrastructure agreement. By July 2, shares had moved down to approximately $3.24, for a decline of roughly 28.6% from the June 2 close. The move lower gained pace after the company announced the $115 million convertible note offering, which raised questions around dilution and near-term capital structure.
Taking a longer view, the quarterly picture looks different. At the start of April, HIVE traded near $1.92. The stock more than doubled in the weeks that followed amid growing HPC revenue, data center expansion updates, and greater recognition of the AI strategy. Even after the recent pullback, HIVE is still up approximately 69% for the quarter, indicating the 30-day move is largely a correction within an ongoing uptrend. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Catalysts Behind the 30-Day Price Action
The main driver during this period was the June 18 announcement that BUZZ HPC had signed a three-year, $220 million sovereign AI GPU cloud contract with Bell Canada and Cohere Inc. The agreement calls for deployment of 2,304 NVIDIA Grace Blackwell GPUs at Bell’s facility in Merritt, British Columbia, to support a Canadian sovereign AI stack for enterprise and government customers. Shares rose more than 10% in pre-market trading on the news and continued higher, reaching $5.34 on June 22.
At the same time, HIVE reported that the Boden Municipal Council in Sweden had approved acquisition of the 32-megawatt Big Boden data center, a site the company had operated as a tenant since 2018. A letter of intent with a Swedish sovereign technology company for a potential 10-year lease added further positive momentum.
The reversal started in earnest on June 25 when HIVE priced an upsized $115 million zero-coupon exchangeable senior notes offering due 2031, up from an initial $100 million plan. The notes carry an exchange price of approximately $4.83 per share, and the company entered capped call transactions to help limit dilution. Even with those measures, the offering highlighted the capital-intensive nature of the AI expansion and prompted profit-taking after the rapid run higher. Broader weakness in Bitcoin prices in late June also weighed on sentiment given the company’s ongoing crypto mining exposure.
Quarterly Drivers and Analyst Upgrades
The broader quarterly advance reflected a fundamental shift in the company’s narrative. HIVE reported fiscal 2026 revenue of $297.8 million, up 158% year-over-year, including a record $19.5 million from the HPC business. Bitcoin hashrate scaled from 6.5 EH/s to 25.1 EH/s while GPU cloud infrastructure was being built out. The $220 million Bell-Cohere contract provided concrete validation of the HPC strategy and gave analysts clearer revenue visibility, with management targeting contracted HPC annual recurring revenue above $100 million once the GB200 systems are live. Multiple analyst upgrades followed, with price targets moving as high as $8 at B. Riley. The combination of triple-digit revenue growth, tangible AI contracts, and expanding data center assets supported the quarterly performance even as the final weeks brought a sharp correction. I also reviewed recent signals on Tickeron’s AI Daily Buy/Sell Signals to put the price action in context.
Key Factors to Watch Going Forward
Execution on the $220 million Bell-Cohere deployment remains the central variable. The GB200 GPU cluster is expected to enter service between late 2026 and early 2027, so updates on timelines, capital expenditures, or additional customer commitments will draw close attention. Finalization of the Swedish Boden lease and progress on the 100-megawatt Paraguay substation project represent other potential catalysts. On the risk side, Bitcoin price volatility continues to matter because mining still contributes a material share of revenue. The convertible note overhang and any future equity raises under the $300 million at-the-market program could also affect trading. Continued HPC revenue growth, margin improvement, and evidence that infrastructure can translate into long-term recurring cash flows will be important to monitor.
Using AI Tools to Navigate Stocks Like HIVE
In my experience following names that move quickly on contract news and financing announcements, having access to structured data and automated signals can help cut through the noise. I’ve spent time with Tickeron’s AI Trading Bots, which offer a range of strategies across equities and other assets. The platform lets users review historical performance, risk parameters, and timeframes before deciding whether a particular approach fits their objectives. For someone monitoring infrastructure and AI-related stocks, these tools provide one way to stay organized amid volatility without replacing individual research and judgment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HIVE sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for HIVE moved above the 200-day moving average on June 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where HIVE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The 10-day RSI Indicator for HIVE moved out of overbought territory on June 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on July 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on June 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .
HIVE moved below its 50-day moving average on July 01, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on July 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HIVE broke above its upper Bollinger Band on June 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HIVE entered a downward trend on July 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.495) is normal, around the industry mean (4.135). P/E Ratio (9.174) is within average values for comparable stocks, (48.491). HIVE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.703). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. P/S Ratio (2.241) is also within normal values, averaging (29.412).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers
Advertisement